Bio-Rad price target raised to $450 from $400 at Citi
The Fly

Bio-Rad price target raised to $450 from $400 at Citi

Citi raised the firm’s price target on Bio-Rad (BIO) to $450 from $400 and keeps a Buy rating on the shares. The company reported solid Q3 results, the analyst tells investors in a research note. The firm says the “clean quarter is certainly welcomed by investors after a challenging stretch of execution.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App